Trial intelligence / Profile preview

Tranexamic Acid in Functional Endoscopic Sinus Surgery

NCT03965767Phase 3Unknown

Sponsor
Ain Shams University
Start
Apr 2019
Primary completion
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of tranexamic acid in chronic rhinosinusitis (CRS) and nasal polyps (4 arms), sponsored by Ain Shams University. Primary endpoint: Surgical field quality based on Boezaart scale. Status: unknown.

02

Drugs

tranexamic acid
03

Conditions

chronic rhinosinusitis (CRS)nasal polyps

Beyond the preview

Go deeper on NCT03965767.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03965767.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call